{"transactions":[{"id":1303487,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84143,"kind":"person","name":"Reveles Xavier Trinidad","position":1,"cik":"0001993507","reported_name":"Reveles Xavier Trinidad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-01-14T21:15:26.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":21604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025."}],"balance_after":41943,"source":{"system":"sec-edgar","filing":"0001493152-25-002149","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225002149/ownership.xml","form_type":"4"}},{"id":1303488,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-01-14T21:15:23.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":37037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025."}],"balance_after":280359,"source":{"system":"sec-edgar","filing":"0001493152-25-002150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225002150/ownership.xml","form_type":"4"}},{"id":1303484,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84142,"kind":"person","name":"Edwards James Michael","position":1,"cik":"0001947547","reported_name":"Edwards James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Common Stock","published_at":"2025-01-14T21:15:21.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":6172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025."}],"balance_after":120128,"source":{"system":"sec-edgar","filing":"0001493152-25-002146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225002146/ownership.xml","form_type":"4"}},{"id":1303483,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2025-01-14T21:15:20.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":8641,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025."}],"balance_after":54765,"source":{"system":"sec-edgar","filing":"0001493152-25-002147","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315225002147/ownership.xml","form_type":"4"}},{"id":1303816,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2025-01-14T16:15:24.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":14814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock that vest pro rata on a monthly basis for 12 months commencing on February 10, 2025."}],"balance_after":1080062,"source":{"system":"sec-edgar","filing":"0001493152-25-002148","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315225002148/ownership.xml","form_type":"4"}},{"id":1375520,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84142,"kind":"person","name":"Edwards James Michael","position":1,"cik":"0001947547","reported_name":"Edwards James Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and CFO"}}],"security":"Common Stock","published_at":"2024-11-06T00:05:50.000Z","date":"2024-11-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest 25% on each of (1) the grant date, (2) the one year anniversary of the grant date, (3) the two year anniversary of the grant date and (4) the three year anniversary of the grant date."}],"balance_after":113956,"source":{"system":"sec-edgar","filing":"0001493152-24-043707","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224043707/ownership.xml","form_type":"4"}},{"id":1463092,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89257,"kind":"person","name":"DIAMOND STUART","position":1,"cik":"0001259438","reported_name":"DIAMOND STUART","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T22:47:14.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":99088,"source":{"system":"sec-edgar","filing":"0001493152-24-026091","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224026091/ownership.xml","form_type":"4"}},{"id":1463086,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T22:47:11.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":163936,"source":{"system":"sec-edgar","filing":"0001493152-24-026089","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224026089/ownership.xml","form_type":"4"}},{"id":1463085,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89255,"kind":"person","name":"Joyce Roby","position":1,"cik":"0001993055","reported_name":"Joyce Roby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T22:47:10.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":66615,"source":{"system":"sec-edgar","filing":"0001493152-24-026090","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224026090/ownership.xml","form_type":"4"}},{"id":1463084,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-07-02T22:47:09.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":243322,"source":{"system":"sec-edgar","filing":"0001493152-24-026087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224026087/ownership.xml","form_type":"4"}},{"id":1463083,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T22:47:07.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":117455,"source":{"system":"sec-edgar","filing":"0001493152-24-026088","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224026088/ownership.xml","form_type":"4"}},{"id":1463869,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-07-02T18:47:13.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":1065248,"source":{"system":"sec-edgar","filing":"0001493152-24-026092","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224026092/ownership.xml","form_type":"4"}},{"id":1463524,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89283,"kind":"person","name":"Platt Jamie","position":1,"cik":"0002003040","reported_name":"Platt Jamie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T18:47:09.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":54748,"source":{"system":"sec-edgar","filing":"0001493152-24-026086","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003040/000149315224026086/ownership.xml","form_type":"4"}},{"id":1463489,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89280,"kind":"person","name":"Rubin Gary D","position":1,"cik":"0001947569","reported_name":"Rubin Gary D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89281,"kind":"organization","name":"Harvey Sandler Revocable Trust","position":2,"cik":"0001323253","reported_name":"Harvey Sandler Revocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T18:47:07.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":33784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024."}],"balance_after":146597,"source":{"system":"sec-edgar","filing":"0001493152-24-026085","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947569/000149315224026085/ownership.xml","form_type":"4"}},{"id":1479073,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89257,"kind":"person","name":"DIAMOND STUART","position":1,"cik":"0001259438","reported_name":"DIAMOND STUART","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-15T00:46:01.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":65304,"source":{"system":"sec-edgar","filing":"0001493152-24-023993","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224023993/ownership.xml","form_type":"4"}},{"id":1479072,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-06-15T00:45:59.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":209538,"source":{"system":"sec-edgar","filing":"0001493152-24-023998","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224023998/ownership.xml","form_type":"4"}},{"id":1479071,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89255,"kind":"person","name":"Joyce Roby","position":1,"cik":"0001993055","reported_name":"Joyce Roby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-15T00:45:57.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":32831,"source":{"system":"sec-edgar","filing":"0001493152-24-023995","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224023995/ownership.xml","form_type":"4"}},{"id":1479070,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-15T00:45:54.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":83671,"source":{"system":"sec-edgar","filing":"0001493152-24-023996","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224023996/ownership.xml","form_type":"4"}},{"id":1479069,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-15T00:45:53.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":130152,"source":{"system":"sec-edgar","filing":"0001493152-24-023992","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224023992/ownership.xml","form_type":"4"}},{"id":1479415,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89280,"kind":"person","name":"Rubin Gary D","position":1,"cik":"0001947569","reported_name":"Rubin Gary D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89281,"kind":"organization","name":"Harvey Sandler Revocable Trust","position":2,"cik":"0001323253","reported_name":"Harvey Sandler Revocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T21:27:07.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":112813,"source":{"system":"sec-edgar","filing":"0001493152-24-024006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947569/000149315224024006/ownership.xml","form_type":"4"}},{"id":1479596,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-06-14T20:46:00.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":1031464,"source":{"system":"sec-edgar","filing":"0001493152-24-023994","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224023994/ownership.xml","form_type":"4"}},{"id":1479437,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89283,"kind":"person","name":"Platt Jamie","position":1,"cik":"0002003040","reported_name":"Platt Jamie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T20:45:56.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":8296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares of common stock, par value $0.007 per share, that vest immediately."}],"balance_after":20964,"source":{"system":"sec-edgar","filing":"0001493152-24-023997","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003040/000149315224023997/ownership.xml","form_type":"4"}},{"id":1536223,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-24T20:00:25.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":false,"shares":64848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vested in 7 equal monthly installments beginning on April 28, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2024-04-28","underlying":"Common Stock","underlying_shares":64848},"source":{"system":"sec-edgar","filing":"0001493152-24-015791","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015791/ownership.xml","form_type":"4"}},{"id":1536222,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-24T20:00:25.000Z","date":"2024-04-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":28264,"price":2.65,"value":74899.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to cover the exercise price of the options exercised."}],"balance_after":201242,"source":{"system":"sec-edgar","filing":"0001493152-24-015791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015791/ownership.xml","form_type":"4"}},{"id":1536221,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-04-24T20:00:25.000Z","date":"2024-04-08","kind":"exercise","planned":false,"acquired":true,"shares":64848,"price":1.16,"value":75223.68,"ownership":{"direct":true},"balance_after":229506,"source":{"system":"sec-edgar","filing":"0001493152-24-015791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015791/ownership.xml","form_type":"4"}},{"id":1536214,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2024-04-24T20:00:23.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":false,"shares":64848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vested in 7 equal monthly installments beginning on April 28, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2024-04-28","underlying":"Common Stock","underlying_shares":64848},"source":{"system":"sec-edgar","filing":"0001493152-24-015790","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015790/ownership.xml","form_type":"4"}},{"id":1536213,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2024-04-24T20:00:23.000Z","date":"2024-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":29031,"price":2.58,"value":74899.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to cover the exercise price of the options exercised."}],"balance_after":46124,"source":{"system":"sec-edgar","filing":"0001493152-24-015790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015790/ownership.xml","form_type":"4"}},{"id":1536212,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2024-04-24T20:00:23.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":true,"shares":64848,"price":1.16,"value":75223.68,"ownership":{"direct":true},"balance_after":75155,"source":{"system":"sec-edgar","filing":"0001493152-24-015790","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224015790/ownership.xml","form_type":"4"}},{"id":1536375,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-24T16:00:20.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":false,"shares":64848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vested in 7 equal monthly installments beginning on April 28, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2024-04-28","underlying":"Common Stock","underlying_shares":64848},"source":{"system":"sec-edgar","filing":"0001493152-24-015789","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224015789/ownership.xml","form_type":"4"}},{"id":1536374,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-24T16:00:20.000Z","date":"2024-04-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":33438,"price":2.24,"value":74901.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld to cover the exercise price of the options exercised."}],"balance_after":1023168,"source":{"system":"sec-edgar","filing":"0001493152-24-015789","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224015789/ownership.xml","form_type":"4"}},{"id":1536373,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-24T16:00:20.000Z","date":"2024-04-03","kind":"exercise","planned":false,"acquired":true,"shares":64848,"price":1.16,"value":75223.68,"ownership":{"direct":true},"balance_after":1056606,"source":{"system":"sec-edgar","filing":"0001493152-24-015789","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224015789/ownership.xml","form_type":"4"}},{"id":1557590,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-29T20:52:15.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":64848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vested in 7 equal monthly installments beginning on May 28, 2014 and the balance of such option vested on December 28, 2014."}],"balance_after":0,"derivative":{"exercise_price":1.115,"expiration_date":"2024-04-28","underlying":"Common Stock","underlying_shares":64848},"source":{"system":"sec-edgar","filing":"0001493152-24-012011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224012011/ownership.xml","form_type":"4"}},{"id":1557589,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-29T20:52:15.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":64848,"price":1.155,"value":74899.44,"ownership":{"direct":true},"balance_after":121856,"source":{"system":"sec-edgar","filing":"0001493152-24-012011","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224012011/ownership.xml","form_type":"4"}},{"id":1557727,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-03-29T16:53:35.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":39474,"price":1.52,"value":60000.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest in full on February 16, 2027, the third anniversary of the grant date."}],"balance_after":991758,"source":{"system":"sec-edgar","filing":"0001493152-24-012014","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224012014/ownership.xml","form_type":"4"}},{"id":1661804,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock","published_at":"2024-02-02T21:25:13.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":6688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024."}],"balance_after":10307,"source":{"system":"sec-edgar","filing":"0001493152-24-004768","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224004768/ownership.xml","form_type":"4"}},{"id":1661803,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-02-02T21:24:04.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":23885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024."}],"balance_after":164658,"source":{"system":"sec-edgar","filing":"0001493152-24-004766","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224004766/ownership.xml","form_type":"4"}},{"id":1661801,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84143,"kind":"person","name":"Reveles Xavier Trinidad","position":1,"cik":"0001993507","reported_name":"Reveles Xavier Trinidad","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-02T21:22:59.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":16720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024."}],"balance_after":20339,"source":{"system":"sec-edgar","filing":"0001493152-24-004764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224004764/ownership.xml","form_type":"4"}},{"id":1661802,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":94675,"kind":"person","name":"Dougherty Michael Philip","position":1,"cik":"0001977228","reported_name":"Dougherty Michael Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-02T21:17:53.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":31847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024."}],"balance_after":84203,"source":{"system":"sec-edgar","filing":"0001493152-24-004757","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224004757/ownership.xml","form_type":"4"}},{"id":1662160,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":94688,"kind":"person","name":"Rebel Vivienne I","position":1,"cik":"0001947548","reported_name":"Rebel Vivienne I","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Sci. & Med. Officer, EVP"}}],"security":"Common Stock","published_at":"2024-02-02T16:21:48.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":31847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024."}],"balance_after":46228,"source":{"system":"sec-edgar","filing":"0001493152-24-004762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947548/000149315224004762/ownership.xml","form_type":"4"}},{"id":1662321,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-02-02T16:20:17.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":11943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted shares, which shares will vest pro rata on a monthly basis for 12 months commencing on February 29, 2024."}],"balance_after":952284,"source":{"system":"sec-edgar","filing":"0001493152-24-004760","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224004760/ownership.xml","form_type":"4"}},{"id":1672069,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:54.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Knight of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year"}],"balance_after":75375,"source":{"system":"sec-edgar","filing":"0001493152-24-003692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003692/ownership.xml","form_type":"4"}},{"id":1672068,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:54.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Mr. Knight of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":62707,"source":{"system":"sec-edgar","filing":"0001493152-24-003692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003692/ownership.xml","form_type":"4"}},{"id":1672067,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-01-25T01:52:47.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Ms. Zannes of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":140773,"source":{"system":"sec-edgar","filing":"0001493152-24-003696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003696/ownership.xml","form_type":"4"}},{"id":1672066,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2024-01-25T01:52:47.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from Issuer to Ms. Zannes of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":128105,"source":{"system":"sec-edgar","filing":"0001493152-24-003696","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003696/ownership.xml","form_type":"4"}},{"id":1672065,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89257,"kind":"person","name":"DIAMOND STUART","position":1,"cik":"0001259438","reported_name":"DIAMOND STUART","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:44.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Diamond of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which\nrepresents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year"}],"balance_after":57008,"source":{"system":"sec-edgar","filing":"0001493152-24-003690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003690/ownership.xml","form_type":"4"}},{"id":1672064,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89257,"kind":"person","name":"DIAMOND STUART","position":1,"cik":"0001259438","reported_name":"DIAMOND STUART","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:44.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Mr. Diamond of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":44340,"source":{"system":"sec-edgar","filing":"0001493152-24-003690","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003690/ownership.xml","form_type":"4"}},{"id":1672063,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":76075,"kind":"person","name":"Meghji Mohsin Y","position":1,"cik":"0001202993","reported_name":"Meghji Mohsin Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:41.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Mr. Meghji of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":109737,"source":{"system":"sec-edgar","filing":"0001493152-24-003693","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003693/ownership.xml","form_type":"4"}},{"id":1672062,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:37.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Anderson of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":57008,"source":{"system":"sec-edgar","filing":"0001493152-24-003689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003689/ownership.xml","form_type":"4"}},{"id":1672061,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T01:52:37.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Mr. Anderson of 11,867 restricted shares of Common Stock on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":44340,"source":{"system":"sec-edgar","filing":"0001493152-24-003689","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003689/ownership.xml","form_type":"4"}},{"id":1672060,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89255,"kind":"person","name":"Joyce Roby","position":1,"cik":"0001993055","reported_name":"Joyce Roby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94942,"kind":"organization","name":"Joyce Living Trust","position":2,"cik":"0001995778","reported_name":"Joyce Living Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CO-TRUSTEE"}}],"security":"Common Stock","published_at":"2024-01-25T01:52:35.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Dr. Joyce of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":24535,"source":{"system":"sec-edgar","filing":"0001493152-24-003697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003697/ownership.xml","form_type":"4"}},{"id":1672059,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89255,"kind":"person","name":"Joyce Roby","position":1,"cik":"0001993055","reported_name":"Joyce Roby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}},{"id":94942,"kind":"organization","name":"Joyce Living Trust","position":2,"cik":"0001995778","reported_name":"Joyce Living Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"CO-TRUSTEE"}}],"security":"Common Stock","published_at":"2024-01-25T01:52:35.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Dr. Joyce of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year"}],"balance_after":11867,"source":{"system":"sec-edgar","filing":"0001493152-24-003697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315224003697/ownership.xml","form_type":"4"}},{"id":1672307,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-24T20:52:56.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Girgenti of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year"}],"balance_after":940341,"source":{"system":"sec-edgar","filing":"0001493152-24-003691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224003691/ownership.xml","form_type":"4"}},{"id":1672306,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-24T20:52:56.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Mr. Girgenti of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":927673,"source":{"system":"sec-edgar","filing":"0001493152-24-003691","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315224003691/ownership.xml","form_type":"4"}},{"id":1672239,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89280,"kind":"person","name":"Rubin Gary D","position":1,"cik":"0001947569","reported_name":"Rubin Gary D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89281,"kind":"organization","name":"Harvey Sandler Revocable Trust","position":2,"cik":"0001323253","reported_name":"Harvey Sandler Revocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-24T20:52:51.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Rubin of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":104517,"source":{"system":"sec-edgar","filing":"0001493152-24-003695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947569/000149315224003695/ownership.xml","form_type":"4"}},{"id":1672238,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89280,"kind":"person","name":"Rubin Gary D","position":1,"cik":"0001947569","reported_name":"Rubin Gary D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89281,"kind":"organization","name":"Harvey Sandler Revocable Trust","position":2,"cik":"0001323253","reported_name":"Harvey Sandler Revocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-01-24T20:52:51.000Z","date":"2023-10-01","kind":"grant","planned":false,"acquired":true,"shares":11867,"price":1.58,"value":18749.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from Issuer to Mr. Rubin of 11,867 restricted shares of Common Stock, on October 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":91849,"source":{"system":"sec-edgar","filing":"0001493152-24-003695","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947569/000149315224003695/ownership.xml","form_type":"4"}},{"id":1672252,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89283,"kind":"person","name":"Platt Jamie","position":1,"cik":"0002003040","reported_name":"Platt Jamie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-24T20:52:34.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":12668,"price":1.48,"value":18748.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from the Issuer to Ms. Platt of 12,668 restricted shares of Common Stock, on January 1, 2024 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":12668,"source":{"system":"sec-edgar","filing":"0001493152-24-003694","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2003040/000149315224003694/ownership.xml","form_type":"4"}},{"id":1810198,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-08-11T16:00:34.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":26315,"price":2.28,"value":59998.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a grant from the Issuer to Mr. Girgenti of 26,315 shares of Common Stock on August 9, 2023 pursuant to the terms of his employment agreement."}],"balance_after":915806,"source":{"system":"sec-edgar","filing":"0001493152-23-027815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315223027815/ownership.xml","form_type":"4"}},{"id":1810197,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-08-11T16:00:34.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Girgenti of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":889491,"source":{"system":"sec-edgar","filing":"0001493152-23-027815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315223027815/ownership.xml","form_type":"4"}},{"id":1810196,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-08-11T16:00:34.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Girgenti of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Girgenti continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":879246,"source":{"system":"sec-edgar","filing":"0001493152-23-027815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315223027815/ownership.xml","form_type":"4"}},{"id":1810195,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-08-11T16:00:34.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Girgenti of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":869326,"source":{"system":"sec-edgar","filing":"0001493152-23-027815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315223027815/ownership.xml","form_type":"4"}},{"id":1833954,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89257,"kind":"person","name":"DIAMOND STUART","position":1,"cik":"0001259438","reported_name":"DIAMOND STUART","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:25.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Diamond of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":32473,"source":{"system":"sec-edgar","filing":"0001493152-23-023822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023822/ownership.xml","form_type":"4"}},{"id":1833953,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89257,"kind":"person","name":"DIAMOND STUART","position":1,"cik":"0001259438","reported_name":"DIAMOND STUART","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:25.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Diamond of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Diamond continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":22228,"source":{"system":"sec-edgar","filing":"0001493152-23-023822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023822/ownership.xml","form_type":"4"}},{"id":1833952,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89257,"kind":"person","name":"DIAMOND STUART","position":1,"cik":"0001259438","reported_name":"DIAMOND STUART","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:25.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Diamond of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":12308,"source":{"system":"sec-edgar","filing":"0001493152-23-023822","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023822/ownership.xml","form_type":"4"}},{"id":1833951,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:23.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Anderson of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":32473,"source":{"system":"sec-edgar","filing":"0001493152-23-023820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023820/ownership.xml","form_type":"4"}},{"id":1833950,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:23.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Anderson of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Anderson continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":22228,"source":{"system":"sec-edgar","filing":"0001493152-23-023820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023820/ownership.xml","form_type":"4"}},{"id":1833949,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89256,"kind":"person","name":"Anderson Robert A.","position":1,"cik":"0001730173","reported_name":"Anderson Robert A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:23.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Anderson of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":12308,"source":{"system":"sec-edgar","filing":"0001493152-23-023820","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023820/ownership.xml","form_type":"4"}},{"id":1833948,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":76075,"kind":"person","name":"Meghji Mohsin Y","position":1,"cik":"0001202993","reported_name":"Meghji Mohsin Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:21.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Meghji of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":97870,"source":{"system":"sec-edgar","filing":"0001493152-23-023819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023819/ownership.xml","form_type":"4"}},{"id":1833947,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":76075,"kind":"person","name":"Meghji Mohsin Y","position":1,"cik":"0001202993","reported_name":"Meghji Mohsin Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:21.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Meghji of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Meghji continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":87625,"source":{"system":"sec-edgar","filing":"0001493152-23-023819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023819/ownership.xml","form_type":"4"}},{"id":1833946,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":76075,"kind":"person","name":"Meghji Mohsin Y","position":1,"cik":"0001202993","reported_name":"Meghji Mohsin Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:21.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Meghji of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":77705,"source":{"system":"sec-edgar","filing":"0001493152-23-023819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023819/ownership.xml","form_type":"4"}},{"id":1833945,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-07-06T20:15:13.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents a grant from the Issuer to Ms. Zannes of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":116238,"source":{"system":"sec-edgar","filing":"0001493152-23-023817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023817/ownership.xml","form_type":"4"}},{"id":1833944,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-07-06T20:15:13.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":26178,"price":1.91,"value":49999.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant of 26,178 shares of Common Stock to Ms. Zannes on June 6, 2023 pursuant to Unanimous Written Consent of the Board of Directors of the Issuer dated November 17, 2022."}],"balance_after":105993,"source":{"system":"sec-edgar","filing":"0001493152-23-023817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023817/ownership.xml","form_type":"4"}},{"id":1833943,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-07-06T20:15:13.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Ms. Zannes of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Ms. Zannes continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":79815,"source":{"system":"sec-edgar","filing":"0001493152-23-023817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023817/ownership.xml","form_type":"4"}},{"id":1833942,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84144,"kind":"person","name":"Zannes Maria","position":1,"cik":"0001481928","reported_name":"Zannes Maria","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2023-07-06T20:15:13.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Ms. Zannes of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":69895,"source":{"system":"sec-edgar","filing":"0001493152-23-023817","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023817/ownership.xml","form_type":"4"}},{"id":1833941,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:11.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Knight of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":50840,"source":{"system":"sec-edgar","filing":"0001493152-23-023816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023816/ownership.xml","form_type":"4"}},{"id":1833940,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:11.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Knight of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Knight continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":40595,"source":{"system":"sec-edgar","filing":"0001493152-23-023816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023816/ownership.xml","form_type":"4"}},{"id":1833939,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T20:15:11.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Knight of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":30675,"source":{"system":"sec-edgar","filing":"0001493152-23-023816","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023816/ownership.xml","form_type":"4"}},{"id":1833936,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":94675,"kind":"person","name":"Dougherty Michael Philip","position":1,"cik":"0001977228","reported_name":"Dougherty Michael Philip","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-06T20:15:11.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":52356,"price":1.91,"value":99999.96,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Company\") to Mr. Dougherty of 52,356 shares of common stock, par value $0.007, pursuant to the terms of an employment offer letter dated April 11, 2023, which was approved by the Board of Directors of the Company on May 11, 2023."}],"balance_after":52356,"source":{"system":"sec-edgar","filing":"0001493152-23-023818","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223023818/ownership.xml","form_type":"4"}},{"id":1834277,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-07-06T16:15:18.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Girgenti of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":889491,"source":{"system":"sec-edgar","filing":"0001493152-23-023821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315223023821/ownership.xml","form_type":"4"}},{"id":1834276,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-07-06T16:15:18.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Girgenti of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Girgenti continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":879246,"source":{"system":"sec-edgar","filing":"0001493152-23-023821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315223023821/ownership.xml","form_type":"4"}},{"id":1834275,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84166,"kind":"person","name":"GIRGENTI STEVEN","position":1,"cik":"0001055530","reported_name":"GIRGENTI STEVEN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-07-06T16:15:18.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Girgenti of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":869326,"source":{"system":"sec-edgar","filing":"0001493152-23-023821","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055530/000149315223023821/ownership.xml","form_type":"4"}},{"id":1834201,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89280,"kind":"person","name":"Rubin Gary D","position":1,"cik":"0001947569","reported_name":"Rubin Gary D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89281,"kind":"organization","name":"Harvey Sandler Revocable Trust","position":2,"cik":"0001323253","reported_name":"Harvey Sandler Revocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T16:15:16.000Z","date":"2023-07-01","kind":"grant","planned":false,"acquired":true,"shares":10245,"price":1.83,"value":18748.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant from the Issuer to Mr. Rubin of 10,245 restricted shares of Common Stock, on July 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":79982,"source":{"system":"sec-edgar","filing":"0001493152-23-023815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1947569/000149315223023815/ownership.xml","form_type":"4"}},{"id":1834200,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89280,"kind":"person","name":"Rubin Gary D","position":1,"cik":"0001947569","reported_name":"Rubin Gary D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89281,"kind":"organization","name":"Harvey Sandler Revocable Trust","position":2,"cik":"0001323253","reported_name":"Harvey Sandler Revocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T16:15:16.000Z","date":"2023-04-15","kind":"grant","planned":false,"acquired":true,"shares":9920,"price":1.89,"value":18748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a grant from the Issuer to Mr. Rubin of 9,920 restricted shares of Common Stock on April 15, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest one-third on the date of grant, one-third on May 1, 2023 and the remaining shares on June 1, 2023, provided Mr. Rubin continues to serve as a director, and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":69737,"source":{"system":"sec-edgar","filing":"0001493152-23-023815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1947569/000149315223023815/ownership.xml","form_type":"4"}},{"id":1834199,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89280,"kind":"person","name":"Rubin Gary D","position":1,"cik":"0001947569","reported_name":"Rubin Gary D","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89281,"kind":"organization","name":"Harvey Sandler Revocable Trust","position":2,"cik":"0001323253","reported_name":"Harvey Sandler Revocable Trust","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-07-06T16:15:16.000Z","date":"2023-01-01","kind":"grant","planned":false,"acquired":true,"shares":8227,"price":2.28,"value":18757.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Rubin of 8,227 restricted shares of common stock, par value $0.007 (the \"Common Stock\"), on January 1, 2023 under the Issuer's 2014 Equity Incentive Plan, which shares of restricted stock will vest ratably over three months of continued service beginning on the date of grant and which represents a restricted stock award valued at $18,750 granted by the Issuer to each of its directors each quarter during the calendar year."}],"balance_after":59817,"source":{"system":"sec-edgar","filing":"0001493152-23-023815","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1947569/000149315223023815/ownership.xml","form_type":"4"}},{"id":1966011,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (right to buy)","published_at":"2023-03-08T00:50:31.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":47935,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"shares","element":"transactionShares","label":"F9","text":"Represents a right to purchase an aggregate of 47,935 shares of Common Stock underlying three warrants at an exercise price of $5.25 per share. The warrants were issued to Mr. Perlmutter on July 20, 2022 as consideration for his agreement to amend his unsecured Note to extend its maturity date to October 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents a right to purchase an aggregate of 47,935 shares of Common Stock underlying three warrants at an exercise price of $5.25 per share. The warrants were issued to Mr. Perlmutter on July 20, 2022 as consideration for his agreement to amend his unsecured Note to extend its maturity date to October 31, 2022."}],"balance_after":47935,"derivative":{"exercise_price":5.25,"exercise_date":"2022-07-20","expiration_date":"2027-07-20","underlying":"Common Stock","underlying_shares":47935},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966010,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":23809,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Represents a right to purchase 23,809 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on December 9, 2021 as consideration for his agreement to amend his unsecured Note to extend its maturity date to May 31, 2022."},{"field":"shares","element":"transactionShares","label":"F8","text":"Represents a right to purchase 23,809 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on December 9, 2021 as consideration for his agreement to amend his unsecured Note to extend its maturity date to May 31, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents a right to purchase 23,809 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on December 9, 2021 as consideration for his agreement to amend his unsecured Note to extend its maturity date to May 31, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Represents a right to purchase 23,809 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on December 9, 2021 as consideration for his agreement to amend his unsecured Note to extend its maturity date to May 31, 2022."}],"balance_after":23809,"derivative":{"exercise_price":6.125,"exercise_date":"2022-09-06","expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":23809},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966009,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":71428,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Represents a right to purchase 71,428 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on November 22, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."},{"field":"shares","element":"transactionShares","label":"F7","text":"Represents a right to purchase 71,428 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on November 22, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents a right to purchase 71,428 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on November 22, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents a right to purchase 71,428 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on November 22, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."}],"balance_after":71428,"derivative":{"exercise_price":6.125,"exercise_date":"2022-09-06","expiration_date":"2026-11-22","underlying":"Common Stock","underlying_shares":71428},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966008,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"grant","acquired":true,"shares":24602,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Represents a right to purchase 24,602 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on August 25, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents a right to purchase 24,602 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on August 25, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents a right to purchase 24,602 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on August 25, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents a right to purchase 24,602 shares of Common Stock underlying a warrant that became initially exercisable in connection with the IPO closing on September 6, 2022 at an exercise price equal to the IPO price of $6.125 per share. The warrant was issued to Mr. Perlmutter on August 25, 2021 as consideration for funds he paid to the Issuer for certain of his Notes."}],"balance_after":24602,"derivative":{"exercise_price":6.125,"exercise_date":"2022-09-06","expiration_date":"2026-08-25","underlying":"Common Stock","underlying_shares":24602},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966007,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"shares":103682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"In connection with the IPO closing on September 6, 2022, the 103,682 shares of Series A Convertible Preferred Stock owned by Mr. Perlmutter automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 14,811 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"In connection with the IPO closing on September 6, 2022, the 103,682 shares of Series A Convertible Preferred Stock owned by Mr. Perlmutter automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 14,811 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"In connection with the IPO closing on September 6, 2022, the 103,682 shares of Series A Convertible Preferred Stock owned by Mr. Perlmutter automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 14,811 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":6.75,"underlying":"Common Stock","underlying_shares":14811},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966006,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Unsecured Convertible Promissory Note","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"price":0,"reported_value":55972.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the IPO closing on September 6, 2022, the $114,991.78 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated October 22, 2020, automatically converted into 27,378 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the IPO closing on September 6, 2022, the $114,991.78 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated October 22, 2020, automatically converted into 27,378 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."}],"balance_after":0,"derivative":{"exercise_price":4.2,"exercise_date":"2022-09-06","expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":27378},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966005,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Convertible Promissory Note","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"price":0,"reported_value":32161.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"In connection with the IPO closing on September 6, 2022, the $368,975.34 of outstanding principal and accrued but unpaid interest of this secured Note, dated October 23, 2019, automatically converted into 87,851 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"In connection with the IPO closing on September 6, 2022, the $368,975.34 of outstanding principal and accrued but unpaid interest of this secured Note, dated October 23, 2019, automatically converted into 87,851 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."}],"balance_after":0,"derivative":{"exercise_price":4.2,"exercise_date":"2022-09-06","expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":87851},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966004,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Secured Convertible Promissory Note","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"price":0,"reported_value":657731.96,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the $133,476.00 of outstanding principal and accrued but unpaid interest of this secured convertible promissory note (a \"Note\"), dated January 14, 2019, automatically converted into 31,780 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the $133,476.00 of outstanding principal and accrued but unpaid interest of this secured convertible promissory note (a \"Note\"), dated January 14, 2019, automatically converted into 31,780 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."}],"balance_after":0,"derivative":{"exercise_price":4.2,"exercise_date":"2022-09-06","expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":31780},"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966003,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.007","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":14811,"price":6.75,"value":99974.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"shares","element":"transactionShares","label":"F5","text":"In connection with the IPO closing on September 6, 2022, the 103,682 shares of Series A Convertible Preferred Stock owned by Mr. Perlmutter automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 14,811 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In connection with the IPO closing on September 6, 2022, the 103,682 shares of Series A Convertible Preferred Stock owned by Mr. Perlmutter automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 14,811 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."}],"balance_after":327909,"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966002,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.007","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":27378,"price":4.2,"value":114987.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"shares","element":"transactionShares","label":"F4","text":"In connection with the IPO closing on September 6, 2022, the $114,991.78 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated October 22, 2020, automatically converted into 27,378 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the IPO closing on September 6, 2022, the $114,991.78 of outstanding principal and accrued but unpaid interest of this unsecured Note, dated October 22, 2020, automatically converted into 27,378 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."}],"balance_after":313098,"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966001,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.007","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":87851,"price":4.2,"value":368974.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"shares","element":"transactionShares","label":"F3","text":"In connection with the IPO closing on September 6, 2022, the $368,975.34 of outstanding principal and accrued but unpaid interest of this secured Note, dated October 23, 2019, automatically converted into 87,851 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the IPO closing on September 6, 2022, the $368,975.34 of outstanding principal and accrued but unpaid interest of this secured Note, dated October 23, 2019, automatically converted into 87,851 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."}],"balance_after":285720,"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966000,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":115844,"kind":"person","name":"Perlmutter Nathan M","position":1,"cik":"0001947867","reported_name":"Perlmutter Nathan M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.007","published_at":"2023-03-08T00:50:31.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":31780,"price":4.2,"value":133476.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the $133,476.00 of outstanding principal and accrued but unpaid interest of this secured convertible promissory note (a \"Note\"), dated January 14, 2019, automatically converted into 31,780 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the $133,476.00 of outstanding principal and accrued but unpaid interest of this secured convertible promissory note (a \"Note\"), dated January 14, 2019, automatically converted into 31,780 shares of Common Stock at a conversion price of $4.20 per share (on a Common Stock equivalent basis)."}],"balance_after":197869,"source":{"system":"sec-edgar","filing":"0001493152-23-006949","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006949/ownership.xml","form_type":"4"}},{"id":1966013,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":76075,"kind":"person","name":"Meghji Mohsin Y","position":1,"cik":"0001202993","reported_name":"Meghji Mohsin Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2023-03-08T00:44:45.000Z","date":"2022-09-06","kind":"exercise","acquired":false,"shares":286349,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the 286,349 shares of Series A Convertible Preferred Stock owned by Mr. Meghji automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 40,907 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the 286,349 shares of Series A Convertible Preferred Stock owned by Mr. Meghji automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 40,907 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the 286,349 shares of Series A Convertible Preferred Stock owned by Mr. Meghji automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 40,907 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":3.67,"underlying":"Common Stock","underlying_shares":40907},"source":{"system":"sec-edgar","filing":"0001493152-23-006945","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006945/ownership.xml","form_type":"4"}},{"id":1966012,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":76075,"kind":"person","name":"Meghji Mohsin Y","position":1,"cik":"0001202993","reported_name":"Meghji Mohsin Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.007","published_at":"2023-03-08T00:44:45.000Z","date":"2022-09-06","kind":"exercise","acquired":true,"shares":40907,"price":3.67,"value":150128.69,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of shares of common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\") and the conversion or exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the Issuer's Common Stock, which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the 286,349 shares of Series A Convertible Preferred Stock owned by Mr. Meghji automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 40,907 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the IPO closing on September 6, 2022, the 286,349 shares of Series A Convertible Preferred Stock owned by Mr. Meghji automatically converted at the then-effective 1 for 7 conversion rate (as adjusted for the Issuer's 1-for-7 reverse stock split) into 40,907 fully paid and nonassessable shares of Common Stock. The Series A Convertible Preferred Stock had no expiration date."}],"balance_after":69478,"source":{"system":"sec-edgar","filing":"0001493152-23-006945","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315223006945/ownership.xml","form_type":"4"}},{"id":2096208,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":84141,"kind":"person","name":"Zannes Timothy P","position":1,"cik":"0001947564","reported_name":"Zannes Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Secretary, EVP, Gen. Counsel"}}],"security":"Common Stock, par value $0.007","published_at":"2022-12-05T21:29:20.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":3619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Zannes of 3,619 restricted shares of the Issuer's common stock, par value $0.007 (the \"Common Stock\"), on November 17, 2022 under the Issuer's 2014 Equity Incentive Plan. The restricted stock will begin vesting on December 17, 2022 in 12 monthly installments, the first 11 of which will be of 301 shares of Common Stock and the last of which will be of the remaining 308 shares of Common Stock, subject to Mr. Zannes's continuous service to the Issuer through each vesting date."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant from bioAffinity Technologies, Inc. (the \"Issuer\") to Mr. Zannes of 3,619 restricted shares of the Issuer's common stock, par value $0.007 (the \"Common Stock\"), on November 17, 2022 under the Issuer's 2014 Equity Incentive Plan. The restricted stock will begin vesting on December 17, 2022 in 12 monthly installments, the first 11 of which will be of 301 shares of Common Stock and the last of which will be of the remaining 308 shares of Common Stock, subject to Mr. Zannes's continuous service to the Issuer through each vesting date."}],"balance_after":3619,"source":{"system":"sec-edgar","filing":"0001493152-22-034472","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315222034472/ownership.xml","form_type":"4"}},{"id":2096207,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-tradeable Warrants (right to buy)","published_at":"2022-12-05T21:12:40.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":8163,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."}],"balance_after":8163,"derivative":{"exercise_price":7.656,"exercise_date":"2022-08-31","expiration_date":"2027-08-31","underlying":"Common Stock","underlying_shares":8163},"source":{"system":"sec-edgar","filing":"0001493152-22-034466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315222034466/ownership.xml","form_type":"4"}},{"id":2096206,"issuer":{"id":8368,"kind":"organization","name":"bioAffinity Technologies, Inc."},"owners":[{"id":89254,"kind":"person","name":"KNIGHT PETER S","position":1,"cik":"0001189792","reported_name":"KNIGHT PETER S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants (right to buy)","published_at":"2022-12-05T21:12:40.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":8163,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of securities and exercise prices reported in this Form 4 reflect the 1-for-7 reverse stock split of the common stock, par value $0.007 (the \"Common Stock\"), of bioAffinity Technologies, Inc. (the \"Issuer\"), which became effective with the State of Delaware on June 23, 2022 in connection with the Issuer's initial public offering (the \"IPO\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities are included within 8,163 Units purchased by Mr. Knight for $6.125 per Unit in the Issuer's IPO. Each Unit consists of one share of Common Stock, one five-year tradeable warrant to purchase one share of Common Stock at an exercise price of $7.35 per share, and one five-year non-tradeable warrant to purchase one share of Common Stock at an exercise price of $7.656 per share."}],"balance_after":8163,"derivative":{"exercise_price":7.35,"exercise_date":"2022-08-31","expiration_date":"2027-08-31","underlying":"Common Stock","underlying_shares":8163},"source":{"system":"sec-edgar","filing":"0001493152-22-034466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1712762/000149315222034466/ownership.xml","form_type":"4"}}],"next_cursor":"2022-12-05T21:12:40.000000Z,2096206"}